EP3796896
PHARMACEUTICAL FORMULATION OF ADRENALINE
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
23.5.2019EP published:
31.12.2025EP application number:
19726391.6
EPO information:
European Patent Register
Max expiry date:
22.5.2039Expiry date:
22.5.2026
Title in English:
PHARMACEUTICAL FORMULATION OF ADRENALINELanguage of the patent:
English
Timeline
Today
23.5.2019EP application
31.12.2025EP Publication
22.5.2026Expires
Owner
Name:
Klaria Pharma Holding ABAddress:
Virdings Allé 2, 754 50 Uppsala, SE
Inventor
Name:
BOYER, ScottAddress:
754 50 Uppsala, SE
Name:
CAI, ShengzhenAddress:
754 50 Uppsala, SE
Name:
HÜBINETTE, FredrikAddress:
754 50 Uppsala, SE
Name:
INGEMARSSON, LeifAddress:
754 50 Uppsala, SE
Priority
Number:
201808462Date:
23.5.2018Country:
GB
Classification
Categories:
A61K 9/70, A61K 31/137, A61K 47/36, A61K 31/135, A61P 37/00